MRVI Statistics
Total Valuation
MRVI has a market cap or net worth of $1.61 billion. The enterprise value is $1.76 billion.
| Market Cap | 1.61B |
| Enterprise Value | 1.76B |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MRVI has 258.19 million shares outstanding. The number of shares has increased by 2.29% in one year.
| Current Share Class | 147.51M |
| Shares Outstanding | 258.19M |
| Shares Change (YoY) | +2.29% |
| Shares Change (QoQ) | +1.07% |
| Owned by Insiders (%) | 5.61% |
| Owned by Institutions (%) | 66.66% |
| Float | 99.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.70 |
| Forward PS | 7.43 |
| PB Ratio | 4.34 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.42 |
| EV / EBITDA | 113.18 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.85 |
| Debt / EBITDA | 20.29 |
| Debt / FCF | n/a |
| Interest Coverage | -1.71 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -13.02% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 7.22% |
| Revenue Per Employee | $501,863 |
| Profits Per Employee | -$186,024 |
| Employee Count | 416 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -408,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +206.14% in the last 52 weeks. The beta is 0.58, so MRVI's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +206.14% |
| 50-Day Moving Average | 5.95 |
| 200-Day Moving Average | 4.10 |
| Relative Strength Index (RSI) | 45.60 |
| Average Volume (20 Days) | 2,605,327 |
Short Selling Information
The latest short interest is 9.27 million, so 3.59% of the outstanding shares have been sold short.
| Short Interest | 9.27M |
| Short Previous Month | 8.81M |
| Short % of Shares Out | 3.59% |
| Short % of Float | 9.35% |
| Short Ratio (days to cover) | 2.68 |
Income Statement
In the last 12 months, MRVI had revenue of $208.78 million and -$77.39 million in losses. Loss per share was -$0.53.
| Revenue | 208.78M |
| Gross Profit | 74.55M |
| Operating Income | -67.48M |
| Pretax Income | -136.49M |
| Net Income | -77.39M |
| EBITDA | 15.53M |
| EBIT | -41.03M |
| Loss Per Share | -$0.53 |
Balance Sheet
The company has $165.92 million in cash and $315.03 million in debt, with a net cash position of -$149.11 million or -$0.58 per share.
| Cash & Cash Equivalents | 165.92M |
| Total Debt | 315.03M |
| Net Cash | -149.11M |
| Net Cash Per Share | -$0.58 |
| Equity (Book Value) | 369.08M |
| Book Value Per Share | 1.43 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -$39.52 million and capital expenditures -$13.09 million, giving a free cash flow of -$52.60 million.
| Operating Cash Flow | -39.52M |
| Capital Expenditures | -13.09M |
| Depreciation & Amortization | 48.37M |
| Net Borrowing | -55.44M |
| Free Cash Flow | -52.60M |
| FCF Per Share | -$0.20 |
Margins
Gross margin is 35.71%, with operating and profit margins of -32.32% and -37.07%.
| Gross Margin | 35.71% |
| Operating Margin | -32.32% |
| Pretax Margin | -65.38% |
| Profit Margin | -37.07% |
| EBITDA Margin | 7.44% |
| EBIT Margin | -19.65% |
| FCF Margin | n/a |
Dividends & Yields
MRVI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.29% |
| Shareholder Yield | -2.29% |
| Earnings Yield | -4.81% |
| FCF Yield | -3.27% |
Analyst Forecast
The average price target for MRVI is $7.10, which is 13.97% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.10 |
| Price Target Difference | 13.97% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 9.33% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |